NCT06516861

Brief Summary

The sample was randomly divided into 3 groups consisting of patients who received Magnesium Sulfate 30 mg/Kg, Lidocaine 1.5 mg/Kg, and Control. These groups will be checked for hemodynamic changes and cortisol values.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Jan 2024

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 31, 2024

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 23, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 24, 2024

Completed
Last Updated

July 24, 2024

Status Verified

July 1, 2024

Enrollment Period

1 day

First QC Date

June 23, 2024

Last Update Submit

July 17, 2024

Conditions

Keywords

CraniotomyIntubationLidocaineMgSO4

Outcome Measures

Primary Outcomes (4)

  • Systolic Blood Pressure

    mmHg

    1 month

  • Diastolic Blood Pressure

    mmHg

    1 month

  • Mean Arterial Pressure (MAP)

    Estimated by using a formula in which the lower (diastolic) blood pressure is doubled and added to the higher (systolic) blood pressure and that composite sum then is divided by 3 to estimate MAP

    1 month

  • Heart Rate

    beats per minute

    1 month

Secondary Outcomes (1)

  • Cortisol Levels

    1 month

Study Arms (3)

MgSO4 intravenous

EXPERIMENTAL

Sample will be given MgSO4 30mg/Kg Intravenous as a premedication drugs before intubation for all patients who had craniotomy surgery

Drug: Magnesium Sulfate 20 MG/ML

Lidocaine intravenous

EXPERIMENTAL

Sample will be given Lidocain 1.5mg/Kg Intravenous as a premedication drugs before intubation for all patients who had craniotomy surgery

Drug: Lidocaine IV

NaCl 0,9% Intravenous

PLACEBO COMPARATOR

Sample will be given NaCl 0,9% Intravenous 20 ml as a premedication drugs before intubation for all patients who had craniotomy surgery

Drug: saline solution

Interventions

Administered intravenously with a dose of 30 mg/kg

Also known as: Magnesium sulfate injection
MgSO4 intravenous

Administered intravenously with a dose of 1.5mg/Kg

Also known as: Lidocaine
Lidocaine intravenous

Administered intravenously with 20 ml

Also known as: NaCl 0,9% Solution
NaCl 0,9% Intravenous

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients aged 18-65 years;
  • body mass index (BMI) 18.5 kg/m2 - 29.9 kg/m2;
  • patients or their families agreed to be used as research subjects;
  • elective non-traumatic craniotomy cases, namely supratentorial brain tumor evacuation, intracerebral hemorrhage evacuation, subdural hemorrhage, cerebrovascular correction.

You may not qualify if:

  • cardiac, hepatic, and renal disorders;
  • patients with pregnancy;
  • hypertension or hypotension before surgery;
  • hypersensitivity to Magnesium Sulfate and/or Lidocaine;
  • patients with chronic use of corticosteroid drugs, calcium channel blockers, magnesium-containing drugs, and opioids;
  • risk of difficult intubation and ventilation according to the LEMON score and MOANS score criteria;
  • impaired cortisol secretion (pituitary tumor or hypothalamic tumor or adrenal gland disorder); and
  • patients with hypocortisol or hypercortisol at T0 serum cortisol examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Adam Malik General Hospital

Medan, North Sumatra, 20136, Indonesia

Location

Related Publications (9)

  • Bousselmi R, Lebbi MA, Bargaoui A, Ben Romdhane M, Messaoudi A, Ben Gabsia A, Ferjani M. Lidocaine reduces endotracheal tube associated side effects when instilled over the glottis but not when used to inflate the cuff: A double blind, placebo-controlled, randomized trial. Tunis Med. 2014 Jan;92(1):29-33.

  • Silpa AR, Koshy KA, Subramanian A, Pradeep KK. Comparison of the efficacy of two doses of dexmedetomidine in attenuating the hemodynamic response to intubation in patients undergoing elective cardiac surgery: A randomized double-blinded study. J Anaesthesiol Clin Pharmacol. 2020 Jan-Mar;36(1):83-87. doi: 10.4103/joacp.JOACP_235_18. Epub 2020 Feb 18.

  • Sriganesh K, Syeda S, Shanthanna H, Venkataramaiah S, Palaniswamy SR. Effect of Opioid Versus Non-Opioid Analgesia on Surgical Pleth Index and Biomarkers of Surgical Stress During Neurosurgery for Brain Tumors: Preliminary Findings. Neurol India. 2020 Sep-Oct;68(5):1101-1105. doi: 10.4103/0028-3886.294559.

  • Finnerty CC, Mabvuure NT, Ali A, Kozar RA, Herndon DN. The surgically induced stress response. JPEN J Parenter Enteral Nutr. 2013 Sep;37(5 Suppl):21S-9S. doi: 10.1177/0148607113496117.

  • Rastogi, S., Yadav, S. K., Agarwal, A., Kumar, S., & Malviya, D. (2020). Biochemical markers and haemodynamic changes of stress response after intubation with direct laryngoscopy versus video laryngoscopy versus fiberoptic intubation: A comparative study. Indian Journal of Clinical Anaesthesia, 7(4), 681-686.

    RESULT
  • Prete A, Yan Q, Al-Tarrah K, Akturk HK, Prokop LJ, Alahdab F, Foster MA, Lord JM, Karavitaki N, Wass JA, Murad MH, Arlt W, Bancos I. The cortisol stress response induced by surgery: A systematic review and meta-analysis. Clin Endocrinol (Oxf). 2018 Nov;89(5):554-567. doi: 10.1111/cen.13820. Epub 2018 Aug 23.

  • Gil-Gouveia R, Goadsby PJ. Neuropsychiatric side-effects of lidocaine: examples from the treatment of headache and a review. Cephalalgia. 2009 May;29(5):496-508. doi: 10.1111/j.1468-2982.2008.01800.x. Epub 2009 Feb 24.

  • Misganaw A, Sitote M, Jemal S, Melese E, Hune M, Seyoum F, Sema A, Bimrew D. Comparison of intravenous magnesium sulphate and lidocaine for attenuation of cardiovascular response to laryngoscopy and endotracheal intubation in elective surgical patients at Zewditu Memorial Hospital Addis Ababa, Ethiopia. PLoS One. 2021 Jun 1;16(6):e0252465. doi: 10.1371/journal.pone.0252465. eCollection 2021.

  • Mendonca FT, de Queiroz LM, Guimaraes CC, Xavier AC. Effects of lidocaine and magnesium sulfate in attenuating hemodynamic response to tracheal intubation: single-center, prospective, double-blind, randomized study. Braz J Anesthesiol. 2017 Jan-Feb;67(1):50-56. doi: 10.1016/j.bjane.2015.08.004. Epub 2016 Nov 22.

MeSH Terms

Interventions

Magnesium SulfateLidocaineSaline Solution

Intervention Hierarchy (Ancestors)

Magnesium CompoundsInorganic ChemicalsSulfatesSulfuric AcidsSulfur AcidsSulfur CompoundsAcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Rr Sinta Irina, MD

    Universitas Sumatera Utara

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
masks the subjects and care provider from knowing which study treatment
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The design of this study used a double-blind randomized controlled clinical trial with pre test post test with control group design, to assess the comparison of hemodynamics and post-intubation cortisol in the administration of intravenous Magnesium sulfate and intravenous Lidocaine. The study sample was all patients who underwent surgery who met the inclusion and exclusion criteria.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Resident Doctor

Study Record Dates

First Submitted

June 23, 2024

First Posted

July 24, 2024

Study Start

January 31, 2024

Primary Completion

February 1, 2024

Study Completion

March 1, 2024

Last Updated

July 24, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations